Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
fecal microbiota transplantation
The First People's Hospital of Lianyungang
Fecal Microbiota Transplantation
1 trial -
fentanyl
Hospital Authority, Hong Kong
Anesthesia, Spinal
1 trial -
folic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Neural Tube Defects - Spina Bifida and Anencephaly
1 trial -
foundational treatment
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
glucocorticoid plus iguratimod
Peking University Third Hospital
Autoimmune Diseases
1 trial -
hAECs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Premature Ovarian Failure
1 trial -
high caloric oral nutritional supplements
The First People's Hospital of Lianyungang
Malnutrition, Child
1 trial -
high protein
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Life Quality
1 trial -
high-energy digestible food E2
The First People's Hospital of Lianyungang
Caesarean Section
1 trial -
human cord blood-derived mononuclear cells (HCB-MNCs)
The First People's Hospital of Lianyungang
Refractory Diabetic Foot
1 trial -
insulin aspart
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
insulin injection 15 minutes before meals
The First People's Hospital of Lianyungang
Diabetes
1 trial -
intraileal infusion
The First People's Hospital of Lianyungang
Incretins
1 trial -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
7 trials -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Learning Disabilities
1 trial -
intravenous immunoglobulin
The First People's Hospital of Lianyungang
Guillain-Barre Syndrome
1 trial -
iodine-containg spareribs soup
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iodine Bioavailability
1 trial -
iptacopan
The First People's Hospital of Lianyungang
Thrombotic Microangiopathy
1 trial -
irinotecan hydrochloride liposome injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Carcinoma
1 trial -
leuprorelin
The First People's Hospital of Lianyungang
Hematopoietic Stem Cell Transplantation
1 trial -
lidocaine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
2 trials -
live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
low-dose stem cell gel group
The First People's Hospital of Lianyungang
Burn Injury
1 trial -
metformin, topiramate
Hospital Authority, Hong Kong
Obesity
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources